UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) (Statement) - USD ($)	Total	Accounts Payable	Preferred Stock	Common Stock	Common Stock Accounts Payable	Additional Paid-in Capital	Additional Paid-in Capital Accounts Payable	Accumulated Deficit
Beginning balance preferred stock outstanding (in shares) at Dec. 31, 2022			0
Beginning balance at Dec. 31, 2022	$ (40,107)		$ 0	$ 1,705		$ 1,528,642		$ (1,570,454)
Beginning balance common stock outstanding (in shares) at Dec. 31, 2022				17,057,085
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrants exercised (in shares)				81,030
Warrant exercises	30,000			$ 8		29,992
Stock issued in conversion of accounts payable and loans payable (in shares)					135,050
Stock issued in settlement of accounts payable and loans payable		$ 50,000			$ 14		$ 49,986
Stock-based compensation	2,442,701					2,442,701
Net loss	(2,637,956)							(2,637,956)
Ending balance preferred stock outstanding (in shares) at Mar. 31, 2023			0
Ending balance common stock outstanding (in shares) at Mar. 31, 2023				17,273,165
Ending balance at Mar. 31, 2023	(155,362)		$ 0	$ 1,727		4,051,321		(4,208,410)
Beginning balance preferred stock outstanding (in shares) at Dec. 31, 2022			0
Beginning balance at Dec. 31, 2022	(40,107)		$ 0	$ 1,705		1,528,642		(1,570,454)
Beginning balance common stock outstanding (in shares) at Dec. 31, 2022				17,057,085
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,328,839)
Ending balance preferred stock outstanding (in shares) at Sep. 30, 2023			0
Ending balance common stock outstanding (in shares) at Sep. 30, 2023				22,756,825
Ending balance at Sep. 30, 2023	16,837,811		$ 0	$ 2,276		26,734,828		(9,899,293)
Beginning balance preferred stock outstanding (in shares) at Mar. 31, 2023			0
Beginning balance at Mar. 31, 2023	(155,362)		$ 0	$ 1,727		4,051,321		(4,208,410)
Beginning balance common stock outstanding (in shares) at Mar. 31, 2023				17,273,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock (in shares)				4,325,043
Sale of common stock	16,012,750			$ 433		16,012,317
Warrants exercised (in shares)				56,552
Warrant exercises	20,938			$ 10		20,928
Stock issued in conversion of accounts payable and loans payable (in shares)				378,140	103,439
Stock issued in settlement of accounts payable and loans payable	1,400,000	$ 382,963		$ 38	$ 10	1,399,962	$ 382,953
Stock-based compensation	1,841,767					1,841,767
Net loss	(3,108,552)							(3,108,552)
Ending balance preferred stock outstanding (in shares) at Jun. 30, 2023			0
Ending balance common stock outstanding (in shares) at Jun. 30, 2023				22,136,339
Ending balance at Jun. 30, 2023	16,394,504		$ 0	$ 2,218		23,709,248		(7,316,962)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock (in shares)				123,333
Sale of common stock	950,000			$ 12		949,988
Warrants exercised (in shares)				64,993
Warrant exercises	10,000			$ 3		9,997
Stock-based compensation, including vested restricted shares	1,563
Stock issued in conversion of accounts payable and loans payable (in shares)				432,160
Stock issued in settlement of accounts payable and loans payable	1,600,000			$ 43		1,599,957
Stock-based compensation	464,075					464,075
Net loss	(2,582,331)							(2,582,331)
Ending balance preferred stock outstanding (in shares) at Sep. 30, 2023			0
Ending balance common stock outstanding (in shares) at Sep. 30, 2023				22,756,825
Ending balance at Sep. 30, 2023	$ 16,837,811		$ 0	$ 2,276		26,734,828		(9,899,293)
Beginning balance preferred stock outstanding (in shares) at Dec. 31, 2023	0		0
Beginning balance at Dec. 31, 2023	$ 17,694,453		$ 0	$ 2,327		30,993,846		(13,301,720)
Beginning balance common stock outstanding (in shares) at Dec. 31, 2023	23,270,404			23,270,404
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued to DHC shareholders in reverse recapitalization (in shares)				7,885,220
Stock issued to DHC shareholders in reverse recapitalization	$ (10,721,488)			$ 789		(10,722,277)
Issuance of common stock pursuant to reseller agreement (in shares)				1,750,000
Issuance of common stock pursuant to Reseller Agreement	13,475,000			$ 175		13,474,825
Sale of common stock (in shares)				645,917
Sale of common stock	6,325,000			$ 65		6,324,935
Warrants exercised (in shares)				40,514
Warrant exercises	15,264			$ 4		15,260
Stock-based compensation	698,705					698,705
Net loss	(6,884,409)							(6,884,409)
Ending balance preferred stock outstanding (in shares) at Mar. 31, 2024			0
Ending balance common stock outstanding (in shares) at Mar. 31, 2024				33,592,055
Ending balance at Mar. 31, 2024	$ 20,602,525		$ 0	$ 3,360		40,785,294		(20,186,129)
Beginning balance preferred stock outstanding (in shares) at Dec. 31, 2023	0		0
Beginning balance at Dec. 31, 2023	$ 17,694,453		$ 0	$ 2,327		30,993,846		(13,301,720)
Beginning balance common stock outstanding (in shares) at Dec. 31, 2023	23,270,404			23,270,404
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (15,757,196)
Ending balance preferred stock outstanding (in shares) at Sep. 30, 2024	0		0
Ending balance common stock outstanding (in shares) at Sep. 30, 2024	37,931,764			36,126,764
Ending balance at Sep. 30, 2024	$ 17,751,577		$ 0	$ 3,794		46,806,699		(29,058,916)
Beginning balance preferred stock outstanding (in shares) at Mar. 31, 2024			0
Beginning balance at Mar. 31, 2024	20,602,525		$ 0	$ 3,360		40,785,294		(20,186,129)
Beginning balance common stock outstanding (in shares) at Mar. 31, 2024				33,592,055
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock (in shares)				877,500
Sale of common stock	1,993,750			$ 198		1,993,552
Warrants exercised (in shares)				13,505
Warrant exercises	5,000			$ 1		4,999
Shares issued in period (in shares)				381,915
Stock-based compensation, including vested restricted shares	768,539			$ 42		768,497
Stock issued in conversion of accounts payable and loans payable (in shares)				93,333
Stock issued in settlement of accounts payable and loans payable	322,008			$ 9		321,999
Net loss	(3,049,704)							(3,049,704)
Ending balance preferred stock outstanding (in shares) at Jun. 30, 2024			0
Ending balance common stock outstanding (in shares) at Jun. 30, 2024				34,958,308
Ending balance at Jun. 30, 2024	20,642,118		$ 0	$ 3,610		43,874,341		(23,235,833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of common stock (in shares)				602,500
Sale of common stock	1,756,187			$ 131		1,756,056
Warrants exercised (in shares)				98,335
Warrant exercises	79,760			$ 10		79,750
Shares issued in period (in shares)				35,461
Stock-based compensation, including vested restricted shares	334,913					334,913
Stock issued in conversion of accounts payable and loans payable (in shares)				280,899
Stock issued in settlement of accounts payable and loans payable	500,000			$ 28		499,972
Stock issued in settlement of accrued expenses (in shares)				151,261
Stock issued in settlement of accrued expenses	261,682			$ 15		261,667
Net loss	$ (5,823,083)							(5,823,083)
Ending balance preferred stock outstanding (in shares) at Sep. 30, 2024	0		0
Ending balance common stock outstanding (in shares) at Sep. 30, 2024	37,931,764			36,126,764
Ending balance at Sep. 30, 2024	$ 17,751,577		$ 0	$ 3,794		$ 46,806,699		$ (29,058,916)